Just reading the Independent Expert's report. It's interesting to see that this report is written for the benefit of TAG shareholders. He did not investigate whether the transaction is "fair and reasonable" to CCE shareholders. Naturally enough he concluded that the transaction is fair to current TAG shareholders, because the estimated value of TAG shares will be quite a bit greater after the transaction than before. To me at least that confirms there will be quite a transfer of wealth from CCE to current TAG shareholders.
We consider the Transaction to be fair. The Transaction is fair because the assessed preferred value of a Tag share following the Transaction exceeds the preferred value of a Tag share before the Transaction.
And we will only hold about 26% of TAG after the transaction. I thought we were supposed to be receiving 1/3 (around 33%):
New shares issued to Carnegie Shareholders (Consideration Shares): 58,507,377
Total shares on issue post-Transaction: 222,835,552
They are raising new funds around 10c, and current TAG SP is around this figure too, so that suggests we receive around $5.8 million in value given our 26% holding in TAG. But in exchange we are giving TAG around $4 million in cash and equivalents (see previous post above), so that suggests to me the EMC business is only worth around $1.8 million if you subtract the $4m cash. And we paid $16m for EMC a few years ago?
I'm no financial genius so perhaps someone else can provide a better explanation of the financials.
- Forums
- ASX - By Stock
- CCE
- Ann: TAG: Notice of EGM and explanatory memo
CCE
carnegie clean energy limited
Add to My Watchlist
3.77%
!
5.1¢

Ann: TAG: Notice of EGM and explanatory memo, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $18.67M |
Open | High | Low | Value | Volume |
5.3¢ | 5.3¢ | 5.1¢ | $2.425K | 46.85K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 226325 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 18000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 166572 | 0.051 |
8 | 514425 | 0.050 |
1 | 107000 | 0.049 |
1 | 102000 | 0.048 |
1 | 10531 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 18000 | 1 |
0.053 | 13646 | 1 |
0.054 | 80000 | 1 |
0.055 | 99811 | 5 |
0.056 | 50377 | 1 |
Last trade - 15.44pm 04/07/2025 (20 minute delay) ? |
Featured News
CCE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online